COMP <GO>
CNA vs MS // ENTERPRISE SCALE & MARKET CAP
CNA Financial Corporation (NYSE) VS. Morgan Stanley (NYSE) • 15-METRIC TALLY: CNA 11
— MS 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MS
LAST: $48.68 (-0.39%) • MKT CAP: $13.22B
market-cap
$13.22B
LAST: $184.30 (-3.00%) • MKT CAP: $298.41B
market-cap
$298.41B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNA VS. MS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNA | MS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 3.00% | +16.70 | CNA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.8x | 31.0x | -26.20 | CNA | /valuation <GO> |
| Free Cash Flow Yield | 18.18% | -7.25% | +25.43 | CNA | /fcf-yield <GO> |
| Operating Margin | 75.00% | 24.60% | +50.40 | CNA | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 20.20% | +47.80 | CNA | /net-margins <GO> |
| Revenue Growth (YoY) | -2.00% | 5.50% | -7.50 | MS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.92% | 2.21% | +5.71 | CNA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.57 | 0.46 | +0.11 | CNA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | CNA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.00% | -0.40 | CNA | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.3 | 43.3 | +14.02 | CNA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 1.04 | -0.12 | MS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.6x | 16.5x | -6.90 | CNA | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $13.22B | $298.41B | -$285.18B | MS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNA REV | MS REV | CNA GROSS % | MS GROSS % | CNA FCF | MS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.58B | $0 | 44.0% | — | $2.40B | -$17.89B |
| FY 2024 | $1.61B | $0 | 44.0% | — | $2.48B | $1.36B |
| FY 2023 | $1.62B | $0 | 44.0% | — | $2.21B | -$33.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNA // BETA 0.92
MS // BETA 1.04